CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.
about
QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experiments.Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 casesRapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile.Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype.Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemiaPrognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafishTrichostatin A inhibits the activation of Hepatic stellate cells by Increasing C/EBP-α Acetylation in vivo and in vitro.Transcriptional Regulation of Macrophages Polarization by MicroRNAs.Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies.
P2860
Q33558221-359FF868-23BE-48FF-8501-B8B8118C72E5Q33772607-91BEC584-BA7A-4FD3-A182-78BE942989DCQ33854384-6DF0ECF7-1EA9-432C-8D3B-8AA58D149CE3Q34577037-71ED3C39-E3DE-405E-890C-2EA9405DD1F1Q35169287-81450D2C-F2FC-4C1A-9260-7A46418FF6CCQ35713371-7D9F58AE-FE3F-4482-9381-C0683B76431AQ35788613-82C748EB-ABE9-4380-855E-B0FDC025865CQ36214703-FB43ED62-E38D-4FEB-932A-DC8AE74CD5EFQ38183943-BC147215-3429-445A-BD7E-6FE4A228D453Q39306735-2CFDA1B8-0E2C-444A-A8AB-367FD0C7132FQ39385110-07BF8C45-0CD4-4F5A-BDBE-98164AE2834CQ39517680-9E335A85-E4E1-424A-B7F0-ABCBBE7A6D46Q41177054-339C2B40-3851-45BD-9CFA-00B7514490AEQ54256508-7EEBA449-4F06-4EE1-BC14-1D49415A48D4Q55101081-0C8F345F-8413-4F46-8F20-FF766FBD6E41Q55651366-A7747343-F555-4EE8-B32F-247AB0E8A257
P2860
CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
CEBPA methylation as a prognos ...... e novo acute myeloid leukemia.
@en
CEBPA methylation as a prognos ...... e novo acute myeloid leukemia.
@nl
type
label
CEBPA methylation as a prognos ...... e novo acute myeloid leukemia.
@en
CEBPA methylation as a prognos ...... e novo acute myeloid leukemia.
@nl
prefLabel
CEBPA methylation as a prognos ...... e novo acute myeloid leukemia.
@en
CEBPA methylation as a prognos ...... e novo acute myeloid leukemia.
@nl
P2860
P50
P356
P1433
P1476
CEBPA methylation as a prognos ...... de novo acute myeloid leukemia
@en
P2860
P2888
P356
10.1038/LEU.2010.222
P577
2010-10-07T00:00:00Z
P5875
P6179
1038599102